4.7 Article

Circulating tumor cells in metastatic colorectal cancer: Efficacy and feasibility of different enrichment methods

Journal

CANCER LETTERS
Volume 293, Issue 1, Pages 117-123

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2010.01.003

Keywords

Circulating tumor cells; Metastatic colorectal cancer; EpCAM; Progression-free survival

Categories

Funding

  1. Austrian Research Promotion Agency (FFG)
  2. Janssen-Cilag Pharma, Austria

Ask authors/readers for more resources

Comprehensive in vitro and in vivo studies comparing EpCAM-based methods with other cytometric CTC enrichment technologies in metastatic colorectal cancer (mCRC) patients are lacking. We compare four manual cytometric methods to detect CTCs in vitro and in mCRC patients. The EpCAM-based technology, MACS HEA MicroBeads (R), showed a significant better tumor cell recovery rate compared to other cytometric methods (p-value <0.0001). CTCs of 38 mCRC patients were enriched with MACS HEA MicroBeads (R). Progression-free survival did significantly differ between mCRC patients without detectable and with >= 1 CTCs (p = 0.007). CTC enrichment with EpCAM coupled antibodies is superior to other cytometric methods and is a feasible method for CTC detection in mCRC patients. (C) 2010 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available